Cymabay Therapeu (CBAY): Eigentümerstruktur Nicht notiert
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Cymabay Therapeu
Mitarbeiter 101
Handelsplatz NASDAQ
Ticker Symbol CBAY
IPO Datum 2014-02-03
Adresse 7601 Dumbarton Circle, Fremont, CA, United States, 94555
Webseite https://www.cymabay.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Sujal A. Shah | President, CEO & Director |
| 2 | Dr. Charles A. McWherter Ph.D. | President of Research & Development and Chief Scientific Officer |
| 3 | Mr. Paul T. Quinlan | General Counsel, Chief Compliance Officer & Corporate Secretary |
| 4 | Mr. Harish Shantharam C.F.A. | CFO, Principal Accounting & Financial Officer |
| 5 | Mr. Ken Boehm | Senior Vice President of Human Resources |
| 6 | Mr. Patrick J. O'Mara | Senior Vice President of Business Development |
| 7 | Dr. Robert L. Martin | Senior Vice President of Manufacturing & Nonclinical Development |
| 8 | Ms. Klara A. Dickinson-Eason | Chief Regulatory & Quality Assurance Officer |
| 9 | Ms. Becki Filice | Senior Vice President of Portfolio & Product Leadership |
| 10 | Mr. Ben Kozub | Head of Commercial |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 8,37% | 0,31 Mrd. USD |
| 2 | RA Capital Management, LLC | 6,05% | 0,23 Mrd. USD |
| 3 | Franklin Resources Inc | 2,85% | 0,11 Mrd. USD |
| 4 | FMR Inc | 2,67% | 0,10 Mrd. USD |
| 5 | State Street Corporation | 2,44% | 0,09 Mrd. USD |
| 6 | Geode Capital Management, LLC | 2,07% | 0,08 Mrd. USD |
| 7 | Deutsche Bank AG | 1,20% | 0,05 Mrd. USD |
| 8 | Goldman Sachs Group Inc | 1,10% | 0,04 Mrd. USD |
| 9 | Affinity Asset Advisors, LLC | 0,95% | 0,04 Mrd. USD |
| 10 | Northern Trust Corp | 0,95% | 0,04 Mrd. USD |
| 11 | Morgan Stanley - Brokerage Accounts | 0,83% | 0,03 Mrd. USD |
| 12 | Nuveen Asset Management, LLC | 0,65% | 0,02 Mrd. USD |
| 13 | Amvescap Plc. | 0,63% | 0,02 Mrd. USD |
| 14 | MPM Oncology Impact Management LP | 0,53% | 0,02 Mrd. USD |
| 15 | Jefferies Financial Group Inc | 0,51% | 0,02 Mrd. USD |
| 16 | Bank of New York Mellon Corp | 0,36% | 0,01 Mrd. USD |
| 17 | Artal Group S A | 0,26% | 0,01 Mrd. USD |
| 18 | Wellington Management Company LLP | 0,18% | 0,01 Mrd. USD |
| 19 | JANE STREET GROUP, LLC | 0,17% | 0,01 Mrd. USD |
| 20 | Barclays PLC | 0,17% | 0,01 Mrd. USD |